Denali Therapeutics (DNLI)'s 30-day implied volatility (IV30) was 46.0% at the close on November 6, 2026, down from 62.5% the day before, against a 52-week range of 35.9% to 117.6%. Its 20-day historical volatility was 48.9%.
Data as of November 6, 2026.